Panoy, Margarito, JR.. H.
HRN: 26-28-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/03/2024
12/09/2024
IV
2.25g
Q8
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes